Epidermolysis Bullosa Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Reproductive Options in Inherited Skin Diseases
Conditions: Ichthyosis; Palmoplantar Keratoses; Epidermolysis Bullosa; Ectodermal Dysplasia; Basal Cell Nevus Syndrome; Birt-Hogg-Dube Syndrome; Tuberous Sclerosis; Xeroderma Pigmentosum; Cutis Laxa; Albinism Sponsors: Maastricht University Medical Center Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials

Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Conditions: Quality of Life; Ichthyosis; Palmoplantar Keratoses; Epidermolysis Bullosa; Ectodermal Dysplasia; Basal Cell Nevus Syndrome; Birt-Hogg-Dube Syndrome; Tuberous Sclerosis; Cutis Laxa; Albinism Interventions: Other: Qualitative interview Sponsors: Maastricht University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials

Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
Conditions: Epidermolysis Bullosa Dystrophica Interventions: Other: Sampling Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials

An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
Conditions: Generalized Epidermolysis Bullosa Simplex Interventions: Drug: AC-203; Drug: Vehicle Sponsors: TWi Biotechnology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials

CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa
Conditions: Epidermolysis Bullosa Dystrophica; Epidermolysis Bullosa, Junctional Interventions: Device: CACIPLIQ20; Drug: Placebo Sponsors: Organ, Tissue, Regeneration, Repair and Replacement; Euraxi Pharma; ARANZ Medical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
Condition: Epidermolysis Bullosa Interventions: Drug: allo-APZ2-OTS; Drug: Placebo Sponsor: RHEACELL GmbH & Co. KG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2023 Category: Research Source Type: clinical trials